N
RAD51
STAT5a/b
apoptosis
glioblastoma cells
iPA
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
26
07
2019
accepted:
12
12
2019
entrez:
30
1
2020
pubmed:
30
1
2020
medline:
30
1
2020
Statut:
epublish
Résumé
Glioblastoma is among the most common malignant brain tumors and has a dismal prognosis due to the poor response to therapeutic regimens such as ionizing radiation and DNA-alkylating agents. In our study, we investigated the radiosensitizing activity of the N
Identifiants
pubmed: 31993371
doi: 10.3389/fonc.2019.01498
pmc: PMC6971108
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1498Informations de copyright
Copyright © 2020 Navarra, Pagano, Pacelli, Crescenzi, Longobardi, Gazzerro, Fiore, Pastorino, Pentimalli, Laezza and Bifulco.
Références
Mol Biol Cell. 2003 Jan;14(1):40-53
pubmed: 12529425
Int J Cancer. 2017 Feb 15;140(4):959-972
pubmed: 27813087
Sci Rep. 2017 Oct 26;7(1):14123
pubmed: 29075041
Cancer Res. 2005 Dec 15;65(24):11384-91
pubmed: 16357146
J Med Chem. 2014 Sep 25;57(18):7798-803
pubmed: 25184810
Cancer Treat Rev. 2015 Jan;41(1):35-45
pubmed: 25467108
Nat Rev Cancer. 2008 Mar;8(3):193-204
pubmed: 18256616
Cancer Res. 2002 Jan 1;62(1):219-25
pubmed: 11782381
Clin Cancer Res. 2008 Feb 1;14(3):931-8
pubmed: 18245557
Oxid Med Cell Longev. 2016;2016:6012642
pubmed: 26649141
Mol Cell. 2017 Jun 15;66(6):801-817
pubmed: 28622525
Neuro Oncol. 2014 Oct;16(10):1313-23
pubmed: 24811392
Int J Cancer. 2018 Jan 1;142(1):176-190
pubmed: 28884474
Trends Cancer. 2015 Dec;1(4):252-265
pubmed: 27088132
Genes Cancer. 2013 Sep;4(9-10):401-8
pubmed: 24349638
Gene Ther. 2007 Aug;14(15):1143-51
pubmed: 17495946
FASEB J. 2014 Mar;28(3):1132-44
pubmed: 24265487
Cancer Res. 2006 Sep 1;66(17):8352-5
pubmed: 16951142
Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1251-5
pubmed: 19545791
Pract Radiat Oncol. 2016 Jul-Aug;6(4):217-25
pubmed: 27211230
Adv Cancer Res. 2010;108:73-112
pubmed: 21034966
Nature. 2001 May 3;411(6833):102-7
pubmed: 11333986
Br J Radiol. 2012 Sep;85(1017):e770-81
pubmed: 22919020
J Leukoc Biol. 2013 Dec;94(6):1207-19
pubmed: 23847096
J Biol Chem. 2001 Jul 6;276(27):24638-44
pubmed: 11320092
Cancer Lett. 2015 Jan 28;356(2 Pt B):454-61
pubmed: 25304378
Cold Spring Harb Perspect Biol. 2013 Sep 01;5(9):null
pubmed: 24003211
Environ Mol Mutagen. 2015 Jul;56(6):491-504
pubmed: 25773265
J Neurooncol. 2017 Sep;134(3):513-521
pubmed: 28762004
Clin Cancer Res. 2018 Apr 15;24(8):1917-1931
pubmed: 29483142
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Cancer Res. 2003 Nov 1;63(21):7377-83
pubmed: 14612536
Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):928-42
pubmed: 15234026
FASEB J. 2006 Mar;20(3):412-8
pubmed: 16507758
J Med Chem. 2012 Apr 12;55(7):3011-20
pubmed: 22380680
Br J Cancer. 2014 Sep 9;111(6):1139-49
pubmed: 25025965
Oncotarget. 2016 Oct 25;7(43):70869-70880
pubmed: 27765919
Anticancer Agents Med Chem. 2008 Feb;8(2):200-4
pubmed: 18288922
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Mol Cancer. 2013 Aug 02;12:86
pubmed: 23915189
Mayo Clin Proc. 2017 Jun;92(6):995-1004
pubmed: 28578786
Eur J Gynaecol Oncol. 2005;26(6):589-98
pubmed: 16398215
Ann Transl Med. 2016 Feb;4(3):54
pubmed: 26904576